Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03454165
Title A Study of BNC105P Combined With Ibrutinib
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Dartmouth-Hitchcock Medical Center
Indications

chronic lymphocytic leukemia/small lymphocytic lymphoma

chronic lymphocytic leukemia

Therapies

BNC105P + Ibrutinib

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.